Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Nyxoah SA (NYXH)

NGM · Medical Instruments & Supplies

$1.43+0.03 (+2.14%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$143.1M
P/E (TTM)
EPS
$-2.47
Div Yield
52W Range
$1.26–$8.59
Beta
0.96

Company overview

Next earnings: 2026-08-05(8d)

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Peers in Medical Instruments & Supplies

All in industry →

Recent press releases

Nyxoah SA has not issued a press release in this window.

SEC filings

All filings →

Nyxoah SA has not filed an SEC document in this window.

Nyxoah SA has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
777,188 sh● NEW
582,548 sh-21.6%
125,951 sh-37.2%
48,060 sh-50.1%
62,789 sh-35.3%
35,324 sh+66.5%
Invst, LLC$74,847
16,271 sh0.0%

People at Nyxoah SA

All people →

No officers or directors have been indexed for Nyxoah SA.

Quarterly financials

Full financials →
Revenue trend
12/24
NI
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.